IP Library › Granted Patent US 12,521,556
Granted Patent B2
US 12,521,556 · App. 18/421,192 · Granted Jan 13, 2026

Patient-learned control of medical device

Inventors: Todd D. Zenisek (Georgetown, TX); Touby A. Drew (Eden Prairie, MN); Brian Andrew Smith (Apple Valley, MN); Juan G. Hincapie (Maple Grove, MN); Leonid M. Litvak (Bet Shemesh, IL)
Assignee: Medtronic, Inc.
A61N1/36135A61N1/0534A61N1/0551A61N1/0568A61N1/37235A61N1/36067A61N1/36082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,556
App. No.
18/421,192
Granted
Jan 13, 2026
Kind
B2
Abstract

A system for selecting a sensitivity level for adjusting an intensity setting for therapy provided to a patient includes one or more processors and one or more processors coupled to the memory. The one or more processors are configured to receive an indication of an input to adjust an intensity setting related to the therapy provided to the patient and determine a sensitivity level for adjustment of the intensity setting based on an efficacy of the therapy provided to the patient. The one or more processors are further configured to determine an updated intensity level for the intensity setting based on the sensitivity level and the input to adjust the intensity setting and output an instruction to cause a medical device to provide the therapy at the updated intensity level.

Claims (45)

1 . A system for selecting a sensitivity level for adjusting an intensity setting for therapy provided to a patient, the system comprising memory and one or more processors coupled to the memory, wherein the one or more processors are configured to:

determine a sensitivity level for adjustment of the intensity setting based on an efficacy of therapy provided to the patient, wherein the sensitivity level indicates an amount by which an intensity of the intensity setting changes;

determine an updated intensity level for the intensity setting based on the sensitivity level and an indication to adjust the intensity setting, wherein to determine the updated intensity level, the one or more processors are configured to increase or decrease the intensity level for the intensity setting by the amount indicated by the sensitivity level; and

output an instruction to cause a medical device to provide the therapy at the updated intensity level.

2 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

determine a current activity level for the patient; and

determine the sensitivity level for adjustment based on the current activity level and the efficacy of the therapy provided to the patient.

3 . The system of claim 2 , wherein, to determine the current activity level for the patient, the one or more processors are configured to determine the activity level based on sensed condition information generated by the medical device.

4 . The system of claim 2 , wherein, to determine the current activity level for the patient, the one or more processors are configured to receive, at an external programmer associated with the medical device, an input indicating the activity level.

5 . The system of claim 2 , wherein, to determine the sensitivity level, the one or more processors are configured to:

increase the sensitivity level for adjustment of the intensity setting, from a current sensitivity level, in response to determining that the current activity level is less than a baseline activity level for the patient; or

decrease the sensitivity level for adjustment of the intensity setting, from the current sensitivity level, in response to determining that the current activity level is greater than the baseline activity level for the patient.

6 . The system of claim 2 , wherein, to determine the sensitivity level, the one or more processors are configured to:

increase the sensitivity level for adjustment of the intensity setting, from a current sensitivity level, in response to determining that the current activity level is greater than a baseline activity level for the patient; and

decrease the sensitivity level for adjustment of the intensity setting, from the current sensitivity level, in response to determining that the current activity level is less than the baseline activity level for the patient.

7 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

determine an amount of sleep during a period of time for the patient; and

determine the sensitivity level for adjustment based on the amount of sleep and the efficacy of the therapy provided to the patient.

8 . The system of claim 7 , wherein, to determine the amount of sleep, the one or more processors are configured to determine the amount of sleep based on sensed condition information generated by the medical device.

9 . The system of claim 7 , wherein, to determine the amount of sleep, the one or more processors are configured to receive, at an external programmer associated with the medical device, an input indicating the amount of sleep.

10 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

determine a sleep position during a period of time for the patient; and

determine the sensitivity level for adjustment based on the sleep position and the efficacy of the therapy provided to the patient.

11 . The system of claim 10 , wherein, to determine the sleep position, the one or more processors are configured to determine the sleep position based on sensed condition information generated by the medical device.

12 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

determine a set of previous therapy parameter adjustments during a period of time for the patient; and

determine the sensitivity level for adjustment based on the set of previous therapy parameter adjustments and the efficacy of the therapy provided to the patient.

13 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

receive, at an external programmer associated with the medical device, an input indicating a pain rating; and

determine the sensitivity level for adjustment based on the pain rating and the efficacy of the therapy provided to the patient.

14 . The system of claim 1 , wherein, to determine the sensitivity level, the one or more processors are configured to:

sense, with the medical device, a set of physiological signals; and

determine the sensitivity level for adjustment based on the set of physiological signals and the efficacy of the therapy provided to the patient.

15 . The system of claim 14 , wherein the set of physiological signals comprises one or more of evoked compound action potential (ECAP) or local field potential (LFP).

16 . The system of claim 1 , wherein, to determine the updated intensity level for the intensity setting, the one or more processors are configured to determine the updated intensity level to be within a preconfigured safety range of intensity levels.

17 . The system of claim 1 , wherein to receive the indication of the patient input, the one or more processors are configured to receive the indication of the patient input at an external programmer associated with the medical device.

18 . The system of claim 1 , wherein the medical device is configured to provide one or more of deep brain stimulation (DBS), spinal cord stimulation (SCS), sacral neuromodulation (SNS), or targeted drug delivery (TDD).

19 . A method for selecting a sensitivity level for adjusting an intensity setting for therapy provided to a patient, the method comprising:

determining, by one or more processors, a sensitivity level for adjustment of the intensity setting based on an efficacy for therapy provided to the patient, wherein the sensitivity level indicates an amount by which an intensity of the intensity setting changes;

determining, by the one or more processors, an updated intensity level for the intensity setting based on the sensitivity level and an indication to adjust the intensity setting, wherein determining the updated intensity level comprises increasing or decreasing the intensity level for the intensity setting by the amount indicated by the sensitivity level; and

outputting, by the one or more processors, an instruction to cause a medical device to provide the therapy at the updated intensity level.

20 . An external programmer for selecting an intensity setting for therapy provided to a patient, the external programmer comprising one or more processors and configured to:

determine a sensitivity level for adjustment of the intensity setting based on an efficacy of the therapy provided to the patient, wherein the sensitivity level indicates an amount by which an intensity of the intensity setting changes;

determine an updated intensity level for the intensity setting based on the sensitivity level and an indication to adjust the intensity setting, wherein to determine the updated intensity level, the external programmer is configured to increase or decrease the intensity level for the intensity setting by the amount indicated by the sensitivity level; and

output an instruction to cause a medical device to provide the therapy at the updated intensity level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2024
From: ZENISEK, TODD D.; DREW, TOUBY A.; SMITH, BRIAN ANDREW; HINCAPIE, JUAN G.; LITVAK, LEONID M.
To: MEDTRONIC, INC.
Reel/Frame 066367/0001 →
Continuity (4)
Continuation 17456327 · Nov 23, 2021
Provisional Application 63212988 · Jun 21, 2021
Provisional Application 63140115 · Jan 21, 2021
Related Publication 20240157148A1 · May 16, 2024
References Cited (20)
US 8150531B2 · Skelton · 2012 [cited by applicant]
US 8396565B2 · Singhal et al. · 2013 [cited by applicant]
US 9919159B2 · Skelton et al. · 2018 [cited by applicant]
US 10449371B2 · Serrano Carmona · 2019 [cited by applicant]
US 10576282B2 · Doan et al. · 2020 [cited by applicant]
US 10610688B2 · Thakur et al. · 2020 [cited by applicant]
US 10806344B2 · Goetz · 2020 [cited by applicant]
US 10864368B2 · Stanslaski et al. · 2020 [cited by applicant]
US 11904170B2 · Zenisek · 2024 [cited by examiner]
US 20070255118A1 · Miesel et al. · 2007 [cited by applicant]
US 20180085584A1 · Thakur et al. · 2018 [cited by applicant]
US 20180207432A1 · Thacker et al. · 2018 [cited by applicant]
US 20190099602A1 · Esteller et al. · 2019 [cited by applicant]
US 20190381320A1 · Bradley et al. · 2019 [cited by applicant]
US 20220226658A1 · Zenisek et al. · 2022 [cited by applicant]
Communication pursuant to Article 94(3) EPC from counterpart European Application No. 21830893.0 dated Feb. 7, 2025, 4 pp. [cited by applicant]
International Preliminary Report on Patentability from International Application No. PCT/US2021/072590 dated Aug. 3, 2023, 8 pp. [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2021/072590, dated Mar. 21, 2022, 14 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 17/456,327, dated Mar. 31, 2023 through Oct. 26, 2023, 25 pp. [cited by applicant]
Communication pursuant to Article 94(3) EPC from counterpart European Application No. 21830893.0 dated Sep. 18, 2025, 3 pp. [cited by applicant]